EirGenix provides not just technology services but integral solutions that you can rely on.
Eirgenix develops high quality biologic products, advancing an extensive pipeline of candidates to improve the lives of patients.
Ongoing cancer therapeutic drug EG12014 (trastuzumab biosimilar) passed the ...
Eirgenix received the accreditation certificate of foreign drug manufacturer from Japan
Eirgenix held the whole New "Protein Drug Commercial Production ...
Eirgenix received "Grand Winner of Best Bioprocess Excellence in Taiwan"...
Our facility is located in Taiwan, and offers the service to clients around the world.